nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—Clozapine—Clonazepam—epilepsy syndrome	0.0523	0.362	CrCrCtD
Ziprasidone—Clozapine—Clobazam—epilepsy syndrome	0.0478	0.331	CrCrCtD
Ziprasidone—Clozapine—Diazepam—epilepsy syndrome	0.0445	0.308	CrCrCtD
Ziprasidone—CHRM3—epilepsy syndrome	0.0403	0.188	CbGaD
Ziprasidone—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0389	0.133	CpDpCtD
Ziprasidone—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0389	0.133	CpDpCtD
Ziprasidone—CHRM1—epilepsy syndrome	0.0376	0.175	CbGaD
Ziprasidone—bipolar disorder—Topiramate—epilepsy syndrome	0.0331	0.113	CpDpCtD
Ziprasidone—CHRM2—epilepsy syndrome	0.0307	0.143	CbGaD
Ziprasidone—HTR7—epilepsy syndrome	0.0306	0.142	CbGaD
Ziprasidone—bipolar disorder—Carbamazepine—epilepsy syndrome	0.0295	0.101	CpDpCtD
Ziprasidone—schizophrenia—Lamotrigine—epilepsy syndrome	0.0281	0.0961	CpDpCtD
Ziprasidone—ADRA2A—epilepsy syndrome	0.0262	0.122	CbGaD
Ziprasidone—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0251	0.0857	CpDpCtD
Ziprasidone—bipolar disorder—Clonazepam—epilepsy syndrome	0.0236	0.0805	CpDpCtD
Ziprasidone—schizophrenia—Carbamazepine—epilepsy syndrome	0.0213	0.0728	CpDpCtD
Ziprasidone—SLC6A4—epilepsy syndrome	0.02	0.0931	CbGaD
Ziprasidone—bipolar disorder—Gabapentin—epilepsy syndrome	0.019	0.0649	CpDpCtD
Ziprasidone—schizophrenia—Valproic Acid—epilepsy syndrome	0.0181	0.0619	CpDpCtD
Ziprasidone—schizophrenia—Clonazepam—epilepsy syndrome	0.017	0.0582	CpDpCtD
Ziprasidone—HTR2A—epilepsy syndrome	0.0154	0.0715	CbGaD
Ziprasidone—CYP2D6—epilepsy syndrome	0.0141	0.0654	CbGaD
Ziprasidone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00822	0.0549	CbGbCtD
Ziprasidone—CYP3A7—Carbamazepine—epilepsy syndrome	0.00688	0.046	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00688	0.046	CbGbCtD
Ziprasidone—CYP3A7—Phenytoin—epilepsy syndrome	0.00617	0.0412	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00617	0.0412	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.0055	0.0368	CbGbCtD
Ziprasidone—CYP3A7—Phenobarbital—epilepsy syndrome	0.0055	0.0368	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00542	0.0363	CbGbCtD
Ziprasidone—CYP3A7—Midazolam—epilepsy syndrome	0.00542	0.0363	CbGbCtD
Ziprasidone—CYP3A7—Diazepam—epilepsy syndrome	0.00521	0.0349	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00521	0.0349	CbGbCtD
Ziprasidone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00516	0.0345	CbGbCtD
Ziprasidone—CYP3A5—Phenytoin—epilepsy syndrome	0.00463	0.0309	CbGbCtD
Ziprasidone—CYP3A5—Phenobarbital—epilepsy syndrome	0.00413	0.0276	CbGbCtD
Ziprasidone—CYP3A5—Midazolam—epilepsy syndrome	0.00407	0.0272	CbGbCtD
Ziprasidone—CYP3A5—Diazepam—epilepsy syndrome	0.00391	0.0261	CbGbCtD
Ziprasidone—CYP1A2—Carbamazepine—epilepsy syndrome	0.00384	0.0257	CbGbCtD
Ziprasidone—CYP1A2—Primidone—epilepsy syndrome	0.00359	0.024	CbGbCtD
Ziprasidone—CYP1A2—Propofol—epilepsy syndrome	0.00321	0.0215	CbGbCtD
Ziprasidone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0032	0.0214	CbGbCtD
Ziprasidone—CYP3A5—Valproic Acid—epilepsy syndrome	0.00308	0.0206	CbGbCtD
Ziprasidone—CYP1A2—Phenobarbital—epilepsy syndrome	0.00307	0.0205	CbGbCtD
Ziprasidone—CYP3A4—Felbamate—epilepsy syndrome	0.00298	0.0199	CbGbCtD
Ziprasidone—CYP3A4—Trimethadione—epilepsy syndrome	0.00298	0.0199	CbGbCtD
Ziprasidone—CYP1A2—Diazepam—epilepsy syndrome	0.00291	0.0195	CbGbCtD
Ziprasidone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0028	0.0187	CbGbCtD
Ziprasidone—CYP2D6—Propofol—epilepsy syndrome	0.00265	0.0177	CbGbCtD
Ziprasidone—CYP3A4—Clonazepam—epilepsy syndrome	0.00253	0.0169	CbGbCtD
Ziprasidone—CYP3A4—Clobazam—epilepsy syndrome	0.00243	0.0162	CbGbCtD
Ziprasidone—CYP1A2—Valproic Acid—epilepsy syndrome	0.00229	0.0153	CbGbCtD
Ziprasidone—CYP3A4—Rufinamide—epilepsy syndrome	0.00206	0.0138	CbGbCtD
Ziprasidone—HTR1D—meninx—epilepsy syndrome	0.00204	0.0597	CbGeAlD
Ziprasidone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00201	0.0135	CbGbCtD
Ziprasidone—CYP3A4—Primidone—epilepsy syndrome	0.00188	0.0126	CbGbCtD
Ziprasidone—CYP3A4—Phenytoin—epilepsy syndrome	0.0018	0.0121	CbGbCtD
Ziprasidone—CYP3A4—Propofol—epilepsy syndrome	0.00168	0.0113	CbGbCtD
Ziprasidone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00161	0.0108	CbGbCtD
Ziprasidone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00161	0.0108	CbGbCtD
Ziprasidone—CYP3A4—Midazolam—epilepsy syndrome	0.00159	0.0106	CbGbCtD
Ziprasidone—CYP3A4—Diazepam—epilepsy syndrome	0.00152	0.0102	CbGbCtD
Ziprasidone—CYP3A4—Zonisamide—epilepsy syndrome	0.00149	0.00995	CbGbCtD
Ziprasidone—CYP3A4—Valproic Acid—epilepsy syndrome	0.0012	0.00804	CbGbCtD
Ziprasidone—HTR2A—phrenic nerve—epilepsy syndrome	0.0011	0.0321	CbGeAlD
Ziprasidone—CYP3A4—Topiramate—epilepsy syndrome	0.00108	0.00725	CbGbCtD
Ziprasidone—HTR3A—vagus nerve—epilepsy syndrome	0.000931	0.0272	CbGeAlD
Ziprasidone—DRD3—telencephalic ventricle—epilepsy syndrome	0.000834	0.0244	CbGeAlD
Ziprasidone—HTR7—locus ceruleus—epilepsy syndrome	0.000787	0.023	CbGeAlD
Ziprasidone—HTR7—vagus nerve—epilepsy syndrome	0.000602	0.0176	CbGeAlD
Ziprasidone—DRD1—telencephalic ventricle—epilepsy syndrome	0.000597	0.0175	CbGeAlD
Ziprasidone—HTR6—ganglion—epilepsy syndrome	0.0005	0.0146	CbGeAlD
Ziprasidone—HTR2A—locus ceruleus—epilepsy syndrome	0.000491	0.0143	CbGeAlD
Ziprasidone—DRD5—ganglion—epilepsy syndrome	0.000486	0.0142	CbGeAlD
Ziprasidone—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000484	0.0141	CbGeAlD
Ziprasidone—HTR1D—telencephalic ventricle—epilepsy syndrome	0.000468	0.0137	CbGeAlD
Ziprasidone—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000464	0.0136	CbGeAlD
Ziprasidone—HTR7—pons—epilepsy syndrome	0.000453	0.0133	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—epilepsy syndrome	0.000418	0.0122	CbGeAlD
Ziprasidone—HTR2A—cerebellar cortex—epilepsy syndrome	0.0004	0.0117	CbGeAlD
Ziprasidone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00039	0.0114	CbGeAlD
Ziprasidone—HTR2A—vagus nerve—epilepsy syndrome	0.000376	0.011	CbGeAlD
Ziprasidone—HTR7—telencephalic ventricle—epilepsy syndrome	0.000373	0.0109	CbGeAlD
Ziprasidone—DRD1—ganglion—epilepsy syndrome	0.000372	0.0109	CbGeAlD
Ziprasidone—HTR3A—ganglion—epilepsy syndrome	0.000359	0.0105	CbGeAlD
Ziprasidone—DRD2—telencephalic ventricle—epilepsy syndrome	0.000353	0.0103	CbGeAlD
Ziprasidone—Lurasidone—HTR7—epilepsy syndrome	0.000318	0.167	CrCbGaD
Ziprasidone—HTR1B—ganglion—epilepsy syndrome	0.000301	0.0088	CbGeAlD
Ziprasidone—HTR1D—ganglion—epilepsy syndrome	0.000292	0.00852	CbGeAlD
Ziprasidone—HTR2C—ganglion—epilepsy syndrome	0.000289	0.00844	CbGeAlD
Ziprasidone—HTR2A—pons—epilepsy syndrome	0.000283	0.00827	CbGeAlD
Ziprasidone—HTR1E—brainstem—epilepsy syndrome	0.000277	0.00809	CbGeAlD
Ziprasidone—SLC6A4—ganglion—epilepsy syndrome	0.000274	0.008	CbGeAlD
Ziprasidone—Lurasidone—ADRA2A—epilepsy syndrome	0.000272	0.143	CrCbGaD
Ziprasidone—HTR1E—forebrain—epilepsy syndrome	0.000267	0.00781	CbGeAlD
Ziprasidone—HTR2A—autonomic nervous system—epilepsy syndrome	0.000261	0.00762	CbGeAlD
Ziprasidone—HTR1E—telencephalon—epilepsy syndrome	0.000246	0.00718	CbGeAlD
Ziprasidone—HTR1A—ganglion—epilepsy syndrome	0.000243	0.0071	CbGeAlD
Ziprasidone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000233	0.0068	CbGeAlD
Ziprasidone—HTR7—ganglion—epilepsy syndrome	0.000232	0.00679	CbGeAlD
Ziprasidone—DRD2—ganglion—epilepsy syndrome	0.00022	0.00642	CbGeAlD
Ziprasidone—HTR6—forebrain—epilepsy syndrome	0.00021	0.00613	CbGeAlD
Ziprasidone—SLC6A4—hindbrain—epilepsy syndrome	0.000208	0.00607	CbGeAlD
Ziprasidone—DRD5—forebrain—epilepsy syndrome	0.000204	0.00597	CbGeAlD
Ziprasidone—HTR6—telencephalon—epilepsy syndrome	0.000193	0.00563	CbGeAlD
Ziprasidone—DRD5—telencephalon—epilepsy syndrome	0.000188	0.00549	CbGeAlD
Ziprasidone—HTR1A—hindbrain—epilepsy syndrome	0.000184	0.00539	CbGeAlD
Ziprasidone—HTR7—hindbrain—epilepsy syndrome	0.000176	0.00515	CbGeAlD
Ziprasidone—ADRA1A—hindbrain—epilepsy syndrome	0.00017	0.00497	CbGeAlD
Ziprasidone—DRD2—hindbrain—epilepsy syndrome	0.000167	0.00487	CbGeAlD
Ziprasidone—DRD1—brainstem—epilepsy syndrome	0.000162	0.00472	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—epilepsy syndrome	0.00016	0.0838	CrCbGaD
Ziprasidone—H1F0—forebrain—epilepsy syndrome	0.000158	0.00462	CbGeAlD
Ziprasidone—HTR3A—brainstem—epilepsy syndrome	0.000156	0.00456	CbGeAlD
Ziprasidone—DRD1—forebrain—epilepsy syndrome	0.000156	0.00456	CbGeAlD
Ziprasidone—HTR1E—head—epilepsy syndrome	0.000153	0.00447	CbGeAlD
Ziprasidone—HTR3A—forebrain—epilepsy syndrome	0.000151	0.0044	CbGeAlD
Ziprasidone—H1F0—telencephalon—epilepsy syndrome	0.000145	0.00424	CbGeAlD
Ziprasidone—HTR1E—nervous system—epilepsy syndrome	0.000145	0.00424	CbGeAlD
Ziprasidone—HTR2A—ganglion—epilepsy syndrome	0.000145	0.00423	CbGeAlD
Ziprasidone—DRD1—telencephalon—epilepsy syndrome	0.000143	0.00419	CbGeAlD
Ziprasidone—HTR1E—central nervous system—epilepsy syndrome	0.00014	0.00408	CbGeAlD
Ziprasidone—HTR3A—telencephalon—epilepsy syndrome	0.000138	0.00405	CbGeAlD
Ziprasidone—CHRM4—head—epilepsy syndrome	0.000134	0.00392	CbGeAlD
Ziprasidone—HTR1B—brainstem—epilepsy syndrome	0.000131	0.00383	CbGeAlD
Ziprasidone—DRD4—brain—epilepsy syndrome	0.000129	0.00376	CbGeAlD
Ziprasidone—CHRM4—nervous system—epilepsy syndrome	0.000127	0.00372	CbGeAlD
Ziprasidone—HTR1D—brainstem—epilepsy syndrome	0.000127	0.0037	CbGeAlD
Ziprasidone—HTR1B—forebrain—epilepsy syndrome	0.000126	0.00369	CbGeAlD
Ziprasidone—CHRM2—forebrain—epilepsy syndrome	0.000126	0.00367	CbGeAlD
Ziprasidone—HTR2C—brainstem—epilepsy syndrome	0.000125	0.00367	CbGeAlD
Ziprasidone—DRD3—head—epilepsy syndrome	0.000125	0.00364	CbGeAlD
Ziprasidone—CHRM4—central nervous system—epilepsy syndrome	0.000122	0.00358	CbGeAlD
Ziprasidone—HTR1D—forebrain—epilepsy syndrome	0.000122	0.00358	CbGeAlD
Ziprasidone—HTR2C—forebrain—epilepsy syndrome	0.000121	0.00354	CbGeAlD
Ziprasidone—HTR6—head—epilepsy syndrome	0.00012	0.00351	CbGeAlD
Ziprasidone—SLC6A4—brainstem—epilepsy syndrome	0.000119	0.00348	CbGeAlD
Ziprasidone—DRD3—nervous system—epilepsy syndrome	0.000118	0.00346	CbGeAlD
Ziprasidone—DRD5—head—epilepsy syndrome	0.000117	0.00342	CbGeAlD
Ziprasidone—HTR1B—telencephalon—epilepsy syndrome	0.000116	0.0034	CbGeAlD
Ziprasidone—CHRM2—telencephalon—epilepsy syndrome	0.000116	0.00338	CbGeAlD
Ziprasidone—SLC6A4—forebrain—epilepsy syndrome	0.000115	0.00336	CbGeAlD
Ziprasidone—CHRM1—forebrain—epilepsy syndrome	0.000114	0.00334	CbGeAlD
Ziprasidone—H1F0—medulla oblongata—epilepsy syndrome	0.000114	0.00333	CbGeAlD
Ziprasidone—DRD3—central nervous system—epilepsy syndrome	0.000114	0.00333	CbGeAlD
Ziprasidone—HTR6—nervous system—epilepsy syndrome	0.000114	0.00333	CbGeAlD
Ziprasidone—HTR1D—telencephalon—epilepsy syndrome	0.000112	0.00329	CbGeAlD
Ziprasidone—HTR2C—telencephalon—epilepsy syndrome	0.000111	0.00326	CbGeAlD
Ziprasidone—HTR1E—brain—epilepsy syndrome	0.000111	0.00324	CbGeAlD
Ziprasidone—DRD5—nervous system—epilepsy syndrome	0.000111	0.00324	CbGeAlD
Ziprasidone—HTR2A—hindbrain—epilepsy syndrome	0.00011	0.00321	CbGeAlD
Ziprasidone—HTR6—central nervous system—epilepsy syndrome	0.00011	0.0032	CbGeAlD
Ziprasidone—DRD5—central nervous system—epilepsy syndrome	0.000107	0.00312	CbGeAlD
Ziprasidone—HTR1A—brainstem—epilepsy syndrome	0.000106	0.00309	CbGeAlD
Ziprasidone—SLC6A4—telencephalon—epilepsy syndrome	0.000106	0.00309	CbGeAlD
Ziprasidone—CHRM1—telencephalon—epilepsy syndrome	0.000105	0.00307	CbGeAlD
Ziprasidone—CHRM5—head—epilepsy syndrome	0.000105	0.00306	CbGeAlD
Ziprasidone—H1F0—midbrain—epilepsy syndrome	0.000104	0.00305	CbGeAlD
Ziprasidone—DRD1—midbrain—epilepsy syndrome	0.000103	0.00301	CbGeAlD
Ziprasidone—CHRM3—forebrain—epilepsy syndrome	0.000102	0.00299	CbGeAlD
Ziprasidone—HTR1A—forebrain—epilepsy syndrome	0.000102	0.00298	CbGeAlD
Ziprasidone—H1F0—spinal cord—epilepsy syndrome	0.000102	0.00297	CbGeAlD
Ziprasidone—HTR7—brainstem—epilepsy syndrome	0.000101	0.00295	CbGeAlD
Ziprasidone—CYP2D6—hindbrain—epilepsy syndrome	0.0001	0.00293	CbGeAlD
Ziprasidone—Aripiprazole—CHRM3—epilepsy syndrome	0.0001	0.0524	CrCbGaD
Ziprasidone—CHRM5—nervous system—epilepsy syndrome	9.94e-05	0.00291	CbGeAlD
Ziprasidone—HTR7—forebrain—epilepsy syndrome	9.74e-05	0.00285	CbGeAlD
Ziprasidone—ADRA1A—brainstem—epilepsy syndrome	9.74e-05	0.00285	CbGeAlD
Ziprasidone—CHRM4—brain—epilepsy syndrome	9.72e-05	0.00284	CbGeAlD
Ziprasidone—ADRA1B—head—epilepsy syndrome	9.58e-05	0.0028	CbGeAlD
Ziprasidone—CHRM5—central nervous system—epilepsy syndrome	9.57e-05	0.0028	CbGeAlD
Ziprasidone—DRD2—brainstem—epilepsy syndrome	9.54e-05	0.00279	CbGeAlD
Ziprasidone—CHRM3—telencephalon—epilepsy syndrome	9.41e-05	0.00275	CbGeAlD
Ziprasidone—ADRA1A—forebrain—epilepsy syndrome	9.4e-05	0.00275	CbGeAlD
Ziprasidone—HTR1A—telencephalon—epilepsy syndrome	9.37e-05	0.00274	CbGeAlD
Ziprasidone—Aripiprazole—CHRM1—epilepsy syndrome	9.32e-05	0.0489	CrCbGaD
Ziprasidone—DRD2—forebrain—epilepsy syndrome	9.21e-05	0.00269	CbGeAlD
Ziprasidone—ADRA1B—nervous system—epilepsy syndrome	9.08e-05	0.00265	CbGeAlD
Ziprasidone—KCNH2—forebrain—epilepsy syndrome	9.07e-05	0.00265	CbGeAlD
Ziprasidone—H1F0—head—epilepsy syndrome	9.04e-05	0.00264	CbGeAlD
Ziprasidone—DRD3—brain—epilepsy syndrome	9.03e-05	0.00264	CbGeAlD
Ziprasidone—Clozapine—HRH3—epilepsy syndrome	8.97e-05	0.0471	CrCbGaD
Ziprasidone—HTR7—telencephalon—epilepsy syndrome	8.96e-05	0.00262	CbGeAlD
Ziprasidone—DRD1—head—epilepsy syndrome	8.93e-05	0.00261	CbGeAlD
Ziprasidone—HTR2C—medulla oblongata—epilepsy syndrome	8.75e-05	0.00256	CbGeAlD
Ziprasidone—ADRA1B—central nervous system—epilepsy syndrome	8.74e-05	0.00256	CbGeAlD
Ziprasidone—HTR6—brain—epilepsy syndrome	8.7e-05	0.00254	CbGeAlD
Ziprasidone—ADRA1A—telencephalon—epilepsy syndrome	8.64e-05	0.00253	CbGeAlD
Ziprasidone—HTR3A—head—epilepsy syndrome	8.62e-05	0.00252	CbGeAlD
Ziprasidone—H1F0—nervous system—epilepsy syndrome	8.57e-05	0.00251	CbGeAlD
Ziprasidone—DRD2—telencephalon—epilepsy syndrome	8.47e-05	0.00248	CbGeAlD
Ziprasidone—DRD5—brain—epilepsy syndrome	8.47e-05	0.00248	CbGeAlD
Ziprasidone—DRD1—nervous system—epilepsy syndrome	8.46e-05	0.00247	CbGeAlD
Ziprasidone—KCNH2—telencephalon—epilepsy syndrome	8.34e-05	0.00244	CbGeAlD
Ziprasidone—HTR1B—midbrain—epilepsy syndrome	8.34e-05	0.00244	CbGeAlD
Ziprasidone—H1F0—central nervous system—epilepsy syndrome	8.25e-05	0.00241	CbGeAlD
Ziprasidone—ADRA2C—telencephalon—epilepsy syndrome	8.23e-05	0.00241	CbGeAlD
Ziprasidone—HTR3A—nervous system—epilepsy syndrome	8.17e-05	0.00239	CbGeAlD
Ziprasidone—DRD1—central nervous system—epilepsy syndrome	8.15e-05	0.00238	CbGeAlD
Ziprasidone—HTR1B—spinal cord—epilepsy syndrome	8.14e-05	0.00238	CbGeAlD
Ziprasidone—HTR1D—midbrain—epilepsy syndrome	8.08e-05	0.00236	CbGeAlD
Ziprasidone—H1F0—cerebellum—epilepsy syndrome	8.06e-05	0.00236	CbGeAlD
Ziprasidone—HTR2C—midbrain—epilepsy syndrome	8e-05	0.00234	CbGeAlD
Ziprasidone—HTR3A—central nervous system—epilepsy syndrome	7.87e-05	0.0023	CbGeAlD
Ziprasidone—HTR2C—spinal cord—epilepsy syndrome	7.8e-05	0.00228	CbGeAlD
Ziprasidone—Aripiprazole—CHRM2—epilepsy syndrome	7.61e-05	0.0399	CrCbGaD
Ziprasidone—CHRM5—brain—epilepsy syndrome	7.6e-05	0.00222	CbGeAlD
Ziprasidone—SLC6A4—midbrain—epilepsy syndrome	7.58e-05	0.00222	CbGeAlD
Ziprasidone—Aripiprazole—HTR7—epilepsy syndrome	7.58e-05	0.0397	CrCbGaD
Ziprasidone—SLC6A4—spinal cord—epilepsy syndrome	7.4e-05	0.00216	CbGeAlD
Ziprasidone—HRH1—forebrain—epilepsy syndrome	7.27e-05	0.00213	CbGeAlD
Ziprasidone—HTR1B—head—epilepsy syndrome	7.23e-05	0.00211	CbGeAlD
Ziprasidone—CHRM2—head—epilepsy syndrome	7.19e-05	0.0021	CbGeAlD
Ziprasidone—ADRA2A—forebrain—epilepsy syndrome	7.14e-05	0.00209	CbGeAlD
Ziprasidone—HTR7—medulla oblongata—epilepsy syndrome	7.04e-05	0.00206	CbGeAlD
Ziprasidone—HTR1D—head—epilepsy syndrome	7e-05	0.00205	CbGeAlD
Ziprasidone—ADRA1B—brain—epilepsy syndrome	6.94e-05	0.00203	CbGeAlD
Ziprasidone—HTR2C—head—epilepsy syndrome	6.93e-05	0.00203	CbGeAlD
Ziprasidone—HTR1B—nervous system—epilepsy syndrome	6.86e-05	0.002	CbGeAlD
Ziprasidone—CHRM2—nervous system—epilepsy syndrome	6.82e-05	0.00199	CbGeAlD
Ziprasidone—HTR1A—midbrain—epilepsy syndrome	6.73e-05	0.00197	CbGeAlD
Ziprasidone—HRH1—telencephalon—epilepsy syndrome	6.69e-05	0.00196	CbGeAlD
Ziprasidone—HTR1D—nervous system—epilepsy syndrome	6.64e-05	0.00194	CbGeAlD
Ziprasidone—HTR1B—central nervous system—epilepsy syndrome	6.6e-05	0.00193	CbGeAlD
Ziprasidone—HTR2C—nervous system—epilepsy syndrome	6.57e-05	0.00192	CbGeAlD
Ziprasidone—SLC6A4—head—epilepsy syndrome	6.57e-05	0.00192	CbGeAlD
Ziprasidone—ADRA2A—telencephalon—epilepsy syndrome	6.57e-05	0.00192	CbGeAlD
Ziprasidone—HTR1A—spinal cord—epilepsy syndrome	6.57e-05	0.00192	CbGeAlD
Ziprasidone—CHRM2—central nervous system—epilepsy syndrome	6.57e-05	0.00192	CbGeAlD
Ziprasidone—KCNH2—medulla oblongata—epilepsy syndrome	6.56e-05	0.00192	CbGeAlD
Ziprasidone—H1F0—brain—epilepsy syndrome	6.55e-05	0.00192	CbGeAlD
Ziprasidone—CHRM1—head—epilepsy syndrome	6.55e-05	0.00191	CbGeAlD
Ziprasidone—Aripiprazole—ADRA2A—epilepsy syndrome	6.5e-05	0.0341	CrCbGaD
Ziprasidone—ADRA2C—medulla oblongata—epilepsy syndrome	6.47e-05	0.00189	CbGeAlD
Ziprasidone—DRD1—brain—epilepsy syndrome	6.47e-05	0.00189	CbGeAlD
Ziprasidone—Trazodone—ADRA2A—epilepsy syndrome	6.47e-05	0.0339	CrCbGaD
Ziprasidone—HTR7—midbrain—epilepsy syndrome	6.43e-05	0.00188	CbGeAlD
Ziprasidone—HTR1D—central nervous system—epilepsy syndrome	6.39e-05	0.00187	CbGeAlD
Ziprasidone—HTR2C—central nervous system—epilepsy syndrome	6.33e-05	0.00185	CbGeAlD
Ziprasidone—HTR2A—brainstem—epilepsy syndrome	6.29e-05	0.00184	CbGeAlD
Ziprasidone—HTR7—spinal cord—epilepsy syndrome	6.28e-05	0.00184	CbGeAlD
Ziprasidone—HTR3A—brain—epilepsy syndrome	6.25e-05	0.00183	CbGeAlD
Ziprasidone—SLC6A4—nervous system—epilepsy syndrome	6.23e-05	0.00182	CbGeAlD
Ziprasidone—CHRM1—nervous system—epilepsy syndrome	6.21e-05	0.00182	CbGeAlD
Ziprasidone—DRD2—midbrain—epilepsy syndrome	6.08e-05	0.00178	CbGeAlD
Ziprasidone—HTR2A—forebrain—epilepsy syndrome	6.07e-05	0.00178	CbGeAlD
Ziprasidone—SLC6A4—central nervous system—epilepsy syndrome	6e-05	0.00175	CbGeAlD
Ziprasidone—KCNH2—midbrain—epilepsy syndrome	5.99e-05	0.00175	CbGeAlD
Ziprasidone—CHRM1—central nervous system—epilepsy syndrome	5.98e-05	0.00175	CbGeAlD
Ziprasidone—ADRA2C—midbrain—epilepsy syndrome	5.91e-05	0.00173	CbGeAlD
Ziprasidone—CHRM3—head—epilepsy syndrome	5.86e-05	0.00171	CbGeAlD
Ziprasidone—KCNH2—spinal cord—epilepsy syndrome	5.85e-05	0.00171	CbGeAlD
Ziprasidone—HTR1A—head—epilepsy syndrome	5.84e-05	0.00171	CbGeAlD
Ziprasidone—ADRA2C—spinal cord—epilepsy syndrome	5.77e-05	0.00169	CbGeAlD
Ziprasidone—CYP2D6—brainstem—epilepsy syndrome	5.73e-05	0.00168	CbGeAlD
Ziprasidone—HTR2A—telencephalon—epilepsy syndrome	5.59e-05	0.00163	CbGeAlD
Ziprasidone—HTR7—head—epilepsy syndrome	5.58e-05	0.00163	CbGeAlD
Ziprasidone—CHRM3—nervous system—epilepsy syndrome	5.56e-05	0.00162	CbGeAlD
Ziprasidone—CYP2D6—forebrain—epilepsy syndrome	5.53e-05	0.00162	CbGeAlD
Ziprasidone—HTR1A—nervous system—epilepsy syndrome	5.53e-05	0.00162	CbGeAlD
Ziprasidone—ADRA1A—head—epilepsy syndrome	5.38e-05	0.00157	CbGeAlD
Ziprasidone—Clozapine—CHRM3—epilepsy syndrome	5.37e-05	0.0282	CrCbGaD
Ziprasidone—CHRM3—central nervous system—epilepsy syndrome	5.35e-05	0.00156	CbGeAlD
Ziprasidone—HTR1A—central nervous system—epilepsy syndrome	5.33e-05	0.00156	CbGeAlD
Ziprasidone—HTR7—nervous system—epilepsy syndrome	5.29e-05	0.00155	CbGeAlD
Ziprasidone—DRD2—head—epilepsy syndrome	5.27e-05	0.00154	CbGeAlD
Ziprasidone—HTR1B—brain—epilepsy syndrome	5.24e-05	0.00153	CbGeAlD
Ziprasidone—CHRM2—brain—epilepsy syndrome	5.21e-05	0.00152	CbGeAlD
Ziprasidone—HTR1A—cerebellum—epilepsy syndrome	5.21e-05	0.00152	CbGeAlD
Ziprasidone—KCNH2—head—epilepsy syndrome	5.2e-05	0.00152	CbGeAlD
Ziprasidone—ADRA2A—medulla oblongata—epilepsy syndrome	5.16e-05	0.00151	CbGeAlD
Ziprasidone—ADRA2C—head—epilepsy syndrome	5.13e-05	0.0015	CbGeAlD
Ziprasidone—ADRA1A—nervous system—epilepsy syndrome	5.1e-05	0.00149	CbGeAlD
Ziprasidone—HTR7—central nervous system—epilepsy syndrome	5.09e-05	0.00149	CbGeAlD
Ziprasidone—CYP2D6—telencephalon—epilepsy syndrome	5.09e-05	0.00149	CbGeAlD
Ziprasidone—HTR1D—brain—epilepsy syndrome	5.07e-05	0.00148	CbGeAlD
Ziprasidone—HTR2C—brain—epilepsy syndrome	5.02e-05	0.00147	CbGeAlD
Ziprasidone—Clozapine—CHRM1—epilepsy syndrome	5.01e-05	0.0263	CrCbGaD
Ziprasidone—DRD2—nervous system—epilepsy syndrome	5e-05	0.00146	CbGeAlD
Ziprasidone—HTR7—cerebellum—epilepsy syndrome	4.98e-05	0.00146	CbGeAlD
Ziprasidone—Aripiprazole—SLC6A4—epilepsy syndrome	4.96e-05	0.026	CrCbGaD
Ziprasidone—Trazodone—SLC6A4—epilepsy syndrome	4.93e-05	0.0259	CrCbGaD
Ziprasidone—KCNH2—nervous system—epilepsy syndrome	4.93e-05	0.00144	CbGeAlD
Ziprasidone—ADRA1A—central nervous system—epilepsy syndrome	4.91e-05	0.00144	CbGeAlD
Ziprasidone—ADRA2C—nervous system—epilepsy syndrome	4.86e-05	0.00142	CbGeAlD
Ziprasidone—DRD2—central nervous system—epilepsy syndrome	4.81e-05	0.00141	CbGeAlD
Ziprasidone—ADRA1A—cerebellum—epilepsy syndrome	4.8e-05	0.0014	CbGeAlD
Ziprasidone—SLC6A4—brain—epilepsy syndrome	4.76e-05	0.00139	CbGeAlD
Ziprasidone—CHRM1—brain—epilepsy syndrome	4.75e-05	0.00139	CbGeAlD
Ziprasidone—KCNH2—central nervous system—epilepsy syndrome	4.74e-05	0.00139	CbGeAlD
Ziprasidone—ADRA2A—midbrain—epilepsy syndrome	4.72e-05	0.00138	CbGeAlD
Ziprasidone—DRD2—cerebellum—epilepsy syndrome	4.7e-05	0.00138	CbGeAlD
Ziprasidone—ADRA2C—central nervous system—epilepsy syndrome	4.68e-05	0.00137	CbGeAlD
Ziprasidone—KCNH2—cerebellum—epilepsy syndrome	4.64e-05	0.00136	CbGeAlD
Ziprasidone—ADRA2A—spinal cord—epilepsy syndrome	4.6e-05	0.00135	CbGeAlD
Ziprasidone—ADRA2C—cerebellum—epilepsy syndrome	4.57e-05	0.00134	CbGeAlD
Ziprasidone—HTR2A—medulla oblongata—epilepsy syndrome	4.39e-05	0.00128	CbGeAlD
Ziprasidone—CHRM3—brain—epilepsy syndrome	4.25e-05	0.00124	CbGeAlD
Ziprasidone—HTR1A—brain—epilepsy syndrome	4.23e-05	0.00124	CbGeAlD
Ziprasidone—HRH1—head—epilepsy syndrome	4.16e-05	0.00122	CbGeAlD
Ziprasidone—Clozapine—CHRM2—epilepsy syndrome	4.09e-05	0.0215	CrCbGaD
Ziprasidone—ADRA2A—head—epilepsy syndrome	4.09e-05	0.0012	CbGeAlD
Ziprasidone—Clozapine—HTR7—epilepsy syndrome	4.07e-05	0.0214	CrCbGaD
Ziprasidone—HTR7—brain—epilepsy syndrome	4.04e-05	0.00118	CbGeAlD
Ziprasidone—HTR2A—midbrain—epilepsy syndrome	4.01e-05	0.00117	CbGeAlD
Ziprasidone—HRH1—nervous system—epilepsy syndrome	3.95e-05	0.00115	CbGeAlD
Ziprasidone—HTR2A—spinal cord—epilepsy syndrome	3.91e-05	0.00114	CbGeAlD
Ziprasidone—ADRA1A—brain—epilepsy syndrome	3.9e-05	0.00114	CbGeAlD
Ziprasidone—ADRA2A—nervous system—epilepsy syndrome	3.88e-05	0.00113	CbGeAlD
Ziprasidone—DRD2—brain—epilepsy syndrome	3.82e-05	0.00112	CbGeAlD
Ziprasidone—Aripiprazole—HTR2A—epilepsy syndrome	3.81e-05	0.02	CrCbGaD
Ziprasidone—HRH1—central nervous system—epilepsy syndrome	3.8e-05	0.00111	CbGeAlD
Ziprasidone—Trazodone—HTR2A—epilepsy syndrome	3.79e-05	0.0199	CrCbGaD
Ziprasidone—KCNH2—brain—epilepsy syndrome	3.77e-05	0.0011	CbGeAlD
Ziprasidone—ADRA2A—central nervous system—epilepsy syndrome	3.73e-05	0.00109	CbGeAlD
Ziprasidone—ADRA2C—brain—epilepsy syndrome	3.72e-05	0.00109	CbGeAlD
Ziprasidone—ADRA2A—cerebellum—epilepsy syndrome	3.65e-05	0.00107	CbGeAlD
Ziprasidone—Clozapine—ADRA2A—epilepsy syndrome	3.49e-05	0.0183	CrCbGaD
Ziprasidone—Aripiprazole—CYP2D6—epilepsy syndrome	3.48e-05	0.0183	CrCbGaD
Ziprasidone—HTR2A—head—epilepsy syndrome	3.48e-05	0.00102	CbGeAlD
Ziprasidone—Trazodone—CYP2D6—epilepsy syndrome	3.47e-05	0.0182	CrCbGaD
Ziprasidone—HTR2A—nervous system—epilepsy syndrome	3.3e-05	0.000964	CbGeAlD
Ziprasidone—HTR2A—central nervous system—epilepsy syndrome	3.17e-05	0.000928	CbGeAlD
Ziprasidone—CYP2D6—head—epilepsy syndrome	3.17e-05	0.000927	CbGeAlD
Ziprasidone—HTR2A—cerebellum—epilepsy syndrome	3.1e-05	0.000907	CbGeAlD
Ziprasidone—CYP3A4—nervous system—epilepsy syndrome	3.05e-05	0.000893	CbGeAlD
Ziprasidone—HRH1—brain—epilepsy syndrome	3.02e-05	0.000882	CbGeAlD
Ziprasidone—CYP2D6—nervous system—epilepsy syndrome	3e-05	0.000878	CbGeAlD
Ziprasidone—ADRA2A—brain—epilepsy syndrome	2.96e-05	0.000867	CbGeAlD
Ziprasidone—CYP3A4—central nervous system—epilepsy syndrome	2.94e-05	0.000859	CbGeAlD
Ziprasidone—CYP2D6—central nervous system—epilepsy syndrome	2.89e-05	0.000846	CbGeAlD
Ziprasidone—CYP2D6—cerebellum—epilepsy syndrome	2.83e-05	0.000827	CbGeAlD
Ziprasidone—Clozapine—CYP2C19—epilepsy syndrome	2.53e-05	0.0133	CrCbGaD
Ziprasidone—HTR2A—brain—epilepsy syndrome	2.52e-05	0.000737	CbGeAlD
Ziprasidone—Aripiprazole—ABCB1—epilepsy syndrome	2.49e-05	0.013	CrCbGaD
Ziprasidone—Trazodone—ABCB1—epilepsy syndrome	2.48e-05	0.013	CrCbGaD
Ziprasidone—CYP2D6—brain—epilepsy syndrome	2.3e-05	0.000671	CbGeAlD
Ziprasidone—Clozapine—HTR2A—epilepsy syndrome	2.05e-05	0.0107	CrCbGaD
Ziprasidone—Clozapine—CYP2D6—epilepsy syndrome	1.87e-05	0.00982	CrCbGaD
Ziprasidone—Clozapine—ABCB1—epilepsy syndrome	1.34e-05	0.00702	CrCbGaD
Ziprasidone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	1.04e-05	0.000103	CcSEcCtD
Ziprasidone—Cough—Pregabalin—epilepsy syndrome	1.04e-05	0.000103	CcSEcCtD
Ziprasidone—Connective tissue disorder—Topiramate—epilepsy syndrome	1.04e-05	0.000102	CcSEcCtD
Ziprasidone—Nausea—Levetiracetam—epilepsy syndrome	1.04e-05	0.000102	CcSEcCtD
Ziprasidone—Rash—Vigabatrin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Dizziness—Felbamate—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Dermatitis—Vigabatrin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Urethral disorder—Topiramate—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Hypersensitivity—Carbamazepine—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Vision blurred—Gabapentin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Headache—Vigabatrin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Hypertension—Pregabalin—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Vomiting—Diazepam—epilepsy syndrome	1.03e-05	0.000102	CcSEcCtD
Ziprasidone—Anorexia—Valproic Acid—epilepsy syndrome	1.02e-05	0.000101	CcSEcCtD
Ziprasidone—Tremor—Gabapentin—epilepsy syndrome	1.02e-05	0.000101	CcSEcCtD
Ziprasidone—Rash—Diazepam—epilepsy syndrome	1.02e-05	0.000101	CcSEcCtD
Ziprasidone—Dermatitis—Diazepam—epilepsy syndrome	1.02e-05	0.000101	CcSEcCtD
Ziprasidone—Visual impairment—Topiramate—epilepsy syndrome	1.02e-05	0.0001	CcSEcCtD
Ziprasidone—Myalgia—Pregabalin—epilepsy syndrome	1.01e-05	0.0001	CcSEcCtD
Ziprasidone—Arthralgia—Pregabalin—epilepsy syndrome	1.01e-05	0.0001	CcSEcCtD
Ziprasidone—Chest pain—Pregabalin—epilepsy syndrome	1.01e-05	0.0001	CcSEcCtD
Ziprasidone—Dizziness—Zonisamide—epilepsy syndrome	1.01e-05	0.0001	CcSEcCtD
Ziprasidone—Headache—Diazepam—epilepsy syndrome	1.01e-05	0.0001	CcSEcCtD
Ziprasidone—Anxiety—Pregabalin—epilepsy syndrome	1.01e-05	9.98e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Clonazepam—epilepsy syndrome	1.01e-05	9.97e-05	CcSEcCtD
Ziprasidone—Anaemia—Gabapentin—epilepsy syndrome	1.01e-05	9.97e-05	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	1.01e-05	9.94e-05	CcSEcCtD
Ziprasidone—Hypotension—Valproic Acid—epilepsy syndrome	1e-05	9.92e-05	CcSEcCtD
Ziprasidone—Asthenia—Carbamazepine—epilepsy syndrome	1e-05	9.92e-05	CcSEcCtD
Ziprasidone—Agitation—Gabapentin—epilepsy syndrome	1e-05	9.91e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Phenytoin—epilepsy syndrome	1e-05	9.91e-05	CcSEcCtD
Ziprasidone—Nausea—Fosphenytoin—epilepsy syndrome	1e-05	9.88e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.97e-06	9.85e-05	CcSEcCtD
Ziprasidone—Angioedema—Gabapentin—epilepsy syndrome	9.97e-06	9.85e-05	CcSEcCtD
Ziprasidone—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.95e-06	9.84e-05	CcSEcCtD
Ziprasidone—Vomiting—Felbamate—epilepsy syndrome	9.94e-06	9.82e-05	CcSEcCtD
Ziprasidone—Dry mouth—Pregabalin—epilepsy syndrome	9.9e-06	9.79e-05	CcSEcCtD
Ziprasidone—Rash—Felbamate—epilepsy syndrome	9.86e-06	9.74e-05	CcSEcCtD
Ziprasidone—Eye disorder—Topiramate—epilepsy syndrome	9.85e-06	9.74e-05	CcSEcCtD
Ziprasidone—Dermatitis—Felbamate—epilepsy syndrome	9.85e-06	9.73e-05	CcSEcCtD
Ziprasidone—Tinnitus—Topiramate—epilepsy syndrome	9.83e-06	9.72e-05	CcSEcCtD
Ziprasidone—Vertigo—Gabapentin—epilepsy syndrome	9.8e-06	9.69e-05	CcSEcCtD
Ziprasidone—Headache—Felbamate—epilepsy syndrome	9.79e-06	9.68e-05	CcSEcCtD
Ziprasidone—Confusional state—Pregabalin—epilepsy syndrome	9.79e-06	9.68e-05	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.78e-06	9.67e-05	CcSEcCtD
Ziprasidone—Cardiac disorder—Topiramate—epilepsy syndrome	9.78e-06	9.67e-05	CcSEcCtD
Ziprasidone—Syncope—Gabapentin—epilepsy syndrome	9.78e-06	9.67e-05	CcSEcCtD
Ziprasidone—Leukopenia—Gabapentin—epilepsy syndrome	9.76e-06	9.65e-05	CcSEcCtD
Ziprasidone—Dizziness—Clonazepam—epilepsy syndrome	9.75e-06	9.64e-05	CcSEcCtD
Ziprasidone—Nausea—Vigabatrin—epilepsy syndrome	9.74e-06	9.63e-05	CcSEcCtD
Ziprasidone—Vomiting—Zonisamide—epilepsy syndrome	9.73e-06	9.62e-05	CcSEcCtD
Ziprasidone—Insomnia—Valproic Acid—epilepsy syndrome	9.71e-06	9.6e-05	CcSEcCtD
Ziprasidone—Asthenia—Lamotrigine—epilepsy syndrome	9.69e-06	9.58e-05	CcSEcCtD
Ziprasidone—Dizziness—Phenytoin—epilepsy syndrome	9.69e-06	9.57e-05	CcSEcCtD
Ziprasidone—Rash—Zonisamide—epilepsy syndrome	9.65e-06	9.54e-05	CcSEcCtD
Ziprasidone—Infection—Pregabalin—epilepsy syndrome	9.64e-06	9.53e-05	CcSEcCtD
Ziprasidone—Paraesthesia—Valproic Acid—epilepsy syndrome	9.64e-06	9.53e-05	CcSEcCtD
Ziprasidone—Palpitations—Gabapentin—epilepsy syndrome	9.64e-06	9.53e-05	CcSEcCtD
Ziprasidone—Dermatitis—Zonisamide—epilepsy syndrome	9.64e-06	9.53e-05	CcSEcCtD
Ziprasidone—Dizziness—Oxcarbazepine—epilepsy syndrome	9.63e-06	9.52e-05	CcSEcCtD
Ziprasidone—Nausea—Diazepam—epilepsy syndrome	9.59e-06	9.48e-05	CcSEcCtD
Ziprasidone—Loss of consciousness—Gabapentin—epilepsy syndrome	9.59e-06	9.48e-05	CcSEcCtD
Ziprasidone—Headache—Zonisamide—epilepsy syndrome	9.58e-06	9.48e-05	CcSEcCtD
Ziprasidone—Dyspnoea—Valproic Acid—epilepsy syndrome	9.57e-06	9.46e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Carbamazepine—epilepsy syndrome	9.57e-06	9.46e-05	CcSEcCtD
Ziprasidone—Angiopathy—Topiramate—epilepsy syndrome	9.56e-06	9.45e-05	CcSEcCtD
Ziprasidone—Shock—Pregabalin—epilepsy syndrome	9.55e-06	9.44e-05	CcSEcCtD
Ziprasidone—Somnolence—Valproic Acid—epilepsy syndrome	9.55e-06	9.44e-05	CcSEcCtD
Ziprasidone—Immune system disorder—Topiramate—epilepsy syndrome	9.52e-06	9.41e-05	CcSEcCtD
Ziprasidone—Nervous system disorder—Pregabalin—epilepsy syndrome	9.52e-06	9.41e-05	CcSEcCtD
Ziprasidone—Cough—Gabapentin—epilepsy syndrome	9.52e-06	9.41e-05	CcSEcCtD
Ziprasidone—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.5e-06	9.4e-05	CcSEcCtD
Ziprasidone—Mediastinal disorder—Topiramate—epilepsy syndrome	9.5e-06	9.39e-05	CcSEcCtD
Ziprasidone—Tachycardia—Pregabalin—epilepsy syndrome	9.47e-06	9.37e-05	CcSEcCtD
Ziprasidone—Chills—Topiramate—epilepsy syndrome	9.46e-06	9.35e-05	CcSEcCtD
Ziprasidone—Dyspepsia—Valproic Acid—epilepsy syndrome	9.45e-06	9.34e-05	CcSEcCtD
Ziprasidone—Skin disorder—Pregabalin—epilepsy syndrome	9.43e-06	9.32e-05	CcSEcCtD
Ziprasidone—Hypertension—Gabapentin—epilepsy syndrome	9.42e-06	9.31e-05	CcSEcCtD
Ziprasidone—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.38e-06	9.28e-05	CcSEcCtD
Ziprasidone—Vomiting—Clonazepam—epilepsy syndrome	9.38e-06	9.27e-05	CcSEcCtD
Ziprasidone—Decreased appetite—Valproic Acid—epilepsy syndrome	9.33e-06	9.23e-05	CcSEcCtD
Ziprasidone—Alopecia—Topiramate—epilepsy syndrome	9.31e-06	9.21e-05	CcSEcCtD
Ziprasidone—Vomiting—Phenytoin—epilepsy syndrome	9.31e-06	9.21e-05	CcSEcCtD
Ziprasidone—Rash—Clonazepam—epilepsy syndrome	9.3e-06	9.19e-05	CcSEcCtD
Ziprasidone—Dermatitis—Clonazepam—epilepsy syndrome	9.29e-06	9.18e-05	CcSEcCtD
Ziprasidone—Myalgia—Gabapentin—epilepsy syndrome	9.28e-06	9.18e-05	CcSEcCtD
Ziprasidone—Chest pain—Gabapentin—epilepsy syndrome	9.28e-06	9.18e-05	CcSEcCtD
Ziprasidone—Arthralgia—Gabapentin—epilepsy syndrome	9.28e-06	9.18e-05	CcSEcCtD
Ziprasidone—Nausea—Felbamate—epilepsy syndrome	9.28e-06	9.18e-05	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.27e-06	9.16e-05	CcSEcCtD
Ziprasidone—Vomiting—Oxcarbazepine—epilepsy syndrome	9.26e-06	9.16e-05	CcSEcCtD
Ziprasidone—Fatigue—Valproic Acid—epilepsy syndrome	9.26e-06	9.15e-05	CcSEcCtD
Ziprasidone—Anxiety—Gabapentin—epilepsy syndrome	9.25e-06	9.15e-05	CcSEcCtD
Ziprasidone—Anorexia—Pregabalin—epilepsy syndrome	9.25e-06	9.15e-05	CcSEcCtD
Ziprasidone—Dizziness—Carbamazepine—epilepsy syndrome	9.25e-06	9.14e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Lamotrigine—epilepsy syndrome	9.24e-06	9.14e-05	CcSEcCtD
Ziprasidone—Headache—Clonazepam—epilepsy syndrome	9.24e-06	9.13e-05	CcSEcCtD
Ziprasidone—Rash—Phenytoin—epilepsy syndrome	9.23e-06	9.13e-05	CcSEcCtD
Ziprasidone—Mental disorder—Topiramate—epilepsy syndrome	9.23e-06	9.13e-05	CcSEcCtD
Ziprasidone—Dermatitis—Phenytoin—epilepsy syndrome	9.23e-06	9.12e-05	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	9.22e-06	9.12e-05	CcSEcCtD
Ziprasidone—Rash—Oxcarbazepine—epilepsy syndrome	9.19e-06	9.08e-05	CcSEcCtD
Ziprasidone—Constipation—Valproic Acid—epilepsy syndrome	9.18e-06	9.08e-05	CcSEcCtD
Ziprasidone—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.18e-06	9.07e-05	CcSEcCtD
Ziprasidone—Headache—Phenytoin—epilepsy syndrome	9.18e-06	9.07e-05	CcSEcCtD
Ziprasidone—Malnutrition—Topiramate—epilepsy syndrome	9.18e-06	9.07e-05	CcSEcCtD
Ziprasidone—Erythema—Topiramate—epilepsy syndrome	9.18e-06	9.07e-05	CcSEcCtD
Ziprasidone—Headache—Oxcarbazepine—epilepsy syndrome	9.13e-06	9.02e-05	CcSEcCtD
Ziprasidone—Nausea—Zonisamide—epilepsy syndrome	9.09e-06	8.98e-05	CcSEcCtD
Ziprasidone—Dry mouth—Gabapentin—epilepsy syndrome	9.08e-06	8.98e-05	CcSEcCtD
Ziprasidone—Hypotension—Pregabalin—epilepsy syndrome	9.07e-06	8.97e-05	CcSEcCtD
Ziprasidone—Flatulence—Topiramate—epilepsy syndrome	9.04e-06	8.94e-05	CcSEcCtD
Ziprasidone—Confusional state—Gabapentin—epilepsy syndrome	8.97e-06	8.87e-05	CcSEcCtD
Ziprasidone—Dizziness—Lamotrigine—epilepsy syndrome	8.94e-06	8.83e-05	CcSEcCtD
Ziprasidone—Vomiting—Carbamazepine—epilepsy syndrome	8.89e-06	8.79e-05	CcSEcCtD
Ziprasidone—Back pain—Topiramate—epilepsy syndrome	8.88e-06	8.77e-05	CcSEcCtD
Ziprasidone—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.85e-06	8.75e-05	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.84e-06	8.74e-05	CcSEcCtD
Ziprasidone—Infection—Gabapentin—epilepsy syndrome	8.84e-06	8.74e-05	CcSEcCtD
Ziprasidone—Muscle spasms—Topiramate—epilepsy syndrome	8.82e-06	8.72e-05	CcSEcCtD
Ziprasidone—Rash—Carbamazepine—epilepsy syndrome	8.82e-06	8.71e-05	CcSEcCtD
Ziprasidone—Dermatitis—Carbamazepine—epilepsy syndrome	8.81e-06	8.71e-05	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.78e-06	8.68e-05	CcSEcCtD
Ziprasidone—Insomnia—Pregabalin—epilepsy syndrome	8.78e-06	8.68e-05	CcSEcCtD
Ziprasidone—Nausea—Clonazepam—epilepsy syndrome	8.76e-06	8.66e-05	CcSEcCtD
Ziprasidone—Headache—Carbamazepine—epilepsy syndrome	8.76e-06	8.66e-05	CcSEcCtD
Ziprasidone—Shock—Gabapentin—epilepsy syndrome	8.76e-06	8.66e-05	CcSEcCtD
Ziprasidone—Nervous system disorder—Gabapentin—epilepsy syndrome	8.73e-06	8.63e-05	CcSEcCtD
Ziprasidone—Paraesthesia—Pregabalin—epilepsy syndrome	8.72e-06	8.62e-05	CcSEcCtD
Ziprasidone—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.71e-06	8.62e-05	CcSEcCtD
Ziprasidone—Nausea—Phenytoin—epilepsy syndrome	8.7e-06	8.6e-05	CcSEcCtD
Ziprasidone—Tachycardia—Gabapentin—epilepsy syndrome	8.69e-06	8.59e-05	CcSEcCtD
Ziprasidone—Dyspnoea—Pregabalin—epilepsy syndrome	8.65e-06	8.56e-05	CcSEcCtD
Ziprasidone—Nausea—Oxcarbazepine—epilepsy syndrome	8.65e-06	8.56e-05	CcSEcCtD
Ziprasidone—Vision blurred—Topiramate—epilepsy syndrome	8.65e-06	8.55e-05	CcSEcCtD
Ziprasidone—Skin disorder—Gabapentin—epilepsy syndrome	8.65e-06	8.55e-05	CcSEcCtD
Ziprasidone—Somnolence—Pregabalin—epilepsy syndrome	8.63e-06	8.53e-05	CcSEcCtD
Ziprasidone—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.6e-06	8.51e-05	CcSEcCtD
Ziprasidone—Tremor—Topiramate—epilepsy syndrome	8.6e-06	8.5e-05	CcSEcCtD
Ziprasidone—Vomiting—Lamotrigine—epilepsy syndrome	8.59e-06	8.49e-05	CcSEcCtD
Ziprasidone—Urticaria—Valproic Acid—epilepsy syndrome	8.53e-06	8.43e-05	CcSEcCtD
Ziprasidone—Rash—Lamotrigine—epilepsy syndrome	8.52e-06	8.42e-05	CcSEcCtD
Ziprasidone—Dermatitis—Lamotrigine—epilepsy syndrome	8.51e-06	8.41e-05	CcSEcCtD
Ziprasidone—Body temperature increased—Valproic Acid—epilepsy syndrome	8.49e-06	8.39e-05	CcSEcCtD
Ziprasidone—Abdominal pain—Valproic Acid—epilepsy syndrome	8.49e-06	8.39e-05	CcSEcCtD
Ziprasidone—Anorexia—Gabapentin—epilepsy syndrome	8.48e-06	8.39e-05	CcSEcCtD
Ziprasidone—Anaemia—Topiramate—epilepsy syndrome	8.48e-06	8.38e-05	CcSEcCtD
Ziprasidone—Headache—Lamotrigine—epilepsy syndrome	8.46e-06	8.37e-05	CcSEcCtD
Ziprasidone—Decreased appetite—Pregabalin—epilepsy syndrome	8.44e-06	8.34e-05	CcSEcCtD
Ziprasidone—Agitation—Topiramate—epilepsy syndrome	8.43e-06	8.34e-05	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.38e-06	8.28e-05	CcSEcCtD
Ziprasidone—Fatigue—Pregabalin—epilepsy syndrome	8.37e-06	8.27e-05	CcSEcCtD
Ziprasidone—Hypotension—Gabapentin—epilepsy syndrome	8.32e-06	8.22e-05	CcSEcCtD
Ziprasidone—Nausea—Carbamazepine—epilepsy syndrome	8.3e-06	8.21e-05	CcSEcCtD
Ziprasidone—Constipation—Pregabalin—epilepsy syndrome	8.3e-06	8.21e-05	CcSEcCtD
Ziprasidone—Vertigo—Topiramate—epilepsy syndrome	8.24e-06	8.15e-05	CcSEcCtD
Ziprasidone—Syncope—Topiramate—epilepsy syndrome	8.23e-06	8.13e-05	CcSEcCtD
Ziprasidone—Leukopenia—Topiramate—epilepsy syndrome	8.21e-06	8.12e-05	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.11e-06	8.02e-05	CcSEcCtD
Ziprasidone—Palpitations—Topiramate—epilepsy syndrome	8.11e-06	8.02e-05	CcSEcCtD
Ziprasidone—Loss of consciousness—Topiramate—epilepsy syndrome	8.06e-06	7.97e-05	CcSEcCtD
Ziprasidone—Insomnia—Gabapentin—epilepsy syndrome	8.05e-06	7.96e-05	CcSEcCtD
Ziprasidone—Nausea—Lamotrigine—epilepsy syndrome	8.03e-06	7.93e-05	CcSEcCtD
Ziprasidone—Cough—Topiramate—epilepsy syndrome	8.01e-06	7.92e-05	CcSEcCtD
Ziprasidone—Feeling abnormal—Pregabalin—epilepsy syndrome	8e-06	7.91e-05	CcSEcCtD
Ziprasidone—Paraesthesia—Gabapentin—epilepsy syndrome	7.99e-06	7.9e-05	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.94e-06	7.85e-05	CcSEcCtD
Ziprasidone—Dyspnoea—Gabapentin—epilepsy syndrome	7.94e-06	7.85e-05	CcSEcCtD
Ziprasidone—Hypertension—Topiramate—epilepsy syndrome	7.92e-06	7.83e-05	CcSEcCtD
Ziprasidone—Somnolence—Gabapentin—epilepsy syndrome	7.91e-06	7.82e-05	CcSEcCtD
Ziprasidone—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.91e-06	7.82e-05	CcSEcCtD
Ziprasidone—Dyspepsia—Gabapentin—epilepsy syndrome	7.84e-06	7.75e-05	CcSEcCtD
Ziprasidone—Chest pain—Topiramate—epilepsy syndrome	7.81e-06	7.72e-05	CcSEcCtD
Ziprasidone—Arthralgia—Topiramate—epilepsy syndrome	7.81e-06	7.72e-05	CcSEcCtD
Ziprasidone—Myalgia—Topiramate—epilepsy syndrome	7.81e-06	7.72e-05	CcSEcCtD
Ziprasidone—Anxiety—Topiramate—epilepsy syndrome	7.78e-06	7.7e-05	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.76e-06	7.67e-05	CcSEcCtD
Ziprasidone—Decreased appetite—Gabapentin—epilepsy syndrome	7.74e-06	7.65e-05	CcSEcCtD
Ziprasidone—Urticaria—Pregabalin—epilepsy syndrome	7.71e-06	7.62e-05	CcSEcCtD
Ziprasidone—Asthenia—Valproic Acid—epilepsy syndrome	7.7e-06	7.62e-05	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.68e-06	7.6e-05	CcSEcCtD
Ziprasidone—Fatigue—Gabapentin—epilepsy syndrome	7.67e-06	7.59e-05	CcSEcCtD
Ziprasidone—Body temperature increased—Pregabalin—epilepsy syndrome	7.67e-06	7.59e-05	CcSEcCtD
Ziprasidone—Abdominal pain—Pregabalin—epilepsy syndrome	7.67e-06	7.59e-05	CcSEcCtD
Ziprasidone—Dry mouth—Topiramate—epilepsy syndrome	7.64e-06	7.55e-05	CcSEcCtD
Ziprasidone—Constipation—Gabapentin—epilepsy syndrome	7.61e-06	7.52e-05	CcSEcCtD
Ziprasidone—Confusional state—Topiramate—epilepsy syndrome	7.55e-06	7.46e-05	CcSEcCtD
Ziprasidone—Infection—Topiramate—epilepsy syndrome	7.44e-06	7.35e-05	CcSEcCtD
Ziprasidone—Shock—Topiramate—epilepsy syndrome	7.37e-06	7.28e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Valproic Acid—epilepsy syndrome	7.35e-06	7.26e-05	CcSEcCtD
Ziprasidone—Nervous system disorder—Topiramate—epilepsy syndrome	7.34e-06	7.26e-05	CcSEcCtD
Ziprasidone—Feeling abnormal—Gabapentin—epilepsy syndrome	7.33e-06	7.25e-05	CcSEcCtD
Ziprasidone—Thrombocytopenia—Topiramate—epilepsy syndrome	7.33e-06	7.25e-05	CcSEcCtD
Ziprasidone—Tachycardia—Topiramate—epilepsy syndrome	7.31e-06	7.23e-05	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.28e-06	7.2e-05	CcSEcCtD
Ziprasidone—Skin disorder—Topiramate—epilepsy syndrome	7.27e-06	7.19e-05	CcSEcCtD
Ziprasidone—Hyperhidrosis—Topiramate—epilepsy syndrome	7.24e-06	7.16e-05	CcSEcCtD
Ziprasidone—Hypersensitivity—Pregabalin—epilepsy syndrome	7.15e-06	7.07e-05	CcSEcCtD
Ziprasidone—Anorexia—Topiramate—epilepsy syndrome	7.14e-06	7.06e-05	CcSEcCtD
Ziprasidone—Dizziness—Valproic Acid—epilepsy syndrome	7.1e-06	7.02e-05	CcSEcCtD
Ziprasidone—Urticaria—Gabapentin—epilepsy syndrome	7.07e-06	6.99e-05	CcSEcCtD
Ziprasidone—Abdominal pain—Gabapentin—epilepsy syndrome	7.04e-06	6.96e-05	CcSEcCtD
Ziprasidone—Body temperature increased—Gabapentin—epilepsy syndrome	7.04e-06	6.96e-05	CcSEcCtD
Ziprasidone—Hypotension—Topiramate—epilepsy syndrome	7e-06	6.92e-05	CcSEcCtD
Ziprasidone—Asthenia—Pregabalin—epilepsy syndrome	6.96e-06	6.89e-05	CcSEcCtD
Ziprasidone—Vomiting—Valproic Acid—epilepsy syndrome	6.83e-06	6.75e-05	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.82e-06	6.74e-05	CcSEcCtD
Ziprasidone—Insomnia—Topiramate—epilepsy syndrome	6.77e-06	6.7e-05	CcSEcCtD
Ziprasidone—Rash—Valproic Acid—epilepsy syndrome	6.77e-06	6.69e-05	CcSEcCtD
Ziprasidone—Dermatitis—Valproic Acid—epilepsy syndrome	6.76e-06	6.69e-05	CcSEcCtD
Ziprasidone—Headache—Valproic Acid—epilepsy syndrome	6.73e-06	6.65e-05	CcSEcCtD
Ziprasidone—Paraesthesia—Topiramate—epilepsy syndrome	6.72e-06	6.65e-05	CcSEcCtD
Ziprasidone—Dyspnoea—Topiramate—epilepsy syndrome	6.68e-06	6.6e-05	CcSEcCtD
Ziprasidone—Somnolence—Topiramate—epilepsy syndrome	6.66e-06	6.58e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Pregabalin—epilepsy syndrome	6.64e-06	6.57e-05	CcSEcCtD
Ziprasidone—Dyspepsia—Topiramate—epilepsy syndrome	6.59e-06	6.52e-05	CcSEcCtD
Ziprasidone—Hypersensitivity—Gabapentin—epilepsy syndrome	6.56e-06	6.48e-05	CcSEcCtD
Ziprasidone—Decreased appetite—Topiramate—epilepsy syndrome	6.51e-06	6.44e-05	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.46e-06	6.39e-05	CcSEcCtD
Ziprasidone—Fatigue—Topiramate—epilepsy syndrome	6.46e-06	6.38e-05	CcSEcCtD
Ziprasidone—Dizziness—Pregabalin—epilepsy syndrome	6.42e-06	6.35e-05	CcSEcCtD
Ziprasidone—Constipation—Topiramate—epilepsy syndrome	6.4e-06	6.33e-05	CcSEcCtD
Ziprasidone—Asthenia—Gabapentin—epilepsy syndrome	6.39e-06	6.31e-05	CcSEcCtD
Ziprasidone—Nausea—Valproic Acid—epilepsy syndrome	6.38e-06	6.3e-05	CcSEcCtD
Ziprasidone—Vomiting—Pregabalin—epilepsy syndrome	6.17e-06	6.1e-05	CcSEcCtD
Ziprasidone—Feeling abnormal—Topiramate—epilepsy syndrome	6.17e-06	6.1e-05	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.12e-06	6.05e-05	CcSEcCtD
Ziprasidone—Rash—Pregabalin—epilepsy syndrome	6.12e-06	6.05e-05	CcSEcCtD
Ziprasidone—Dermatitis—Pregabalin—epilepsy syndrome	6.11e-06	6.04e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Gabapentin—epilepsy syndrome	6.09e-06	6.02e-05	CcSEcCtD
Ziprasidone—Headache—Pregabalin—epilepsy syndrome	6.08e-06	6.01e-05	CcSEcCtD
Ziprasidone—Urticaria—Topiramate—epilepsy syndrome	5.95e-06	5.88e-05	CcSEcCtD
Ziprasidone—Abdominal pain—Topiramate—epilepsy syndrome	5.92e-06	5.85e-05	CcSEcCtD
Ziprasidone—Body temperature increased—Topiramate—epilepsy syndrome	5.92e-06	5.85e-05	CcSEcCtD
Ziprasidone—Dizziness—Gabapentin—epilepsy syndrome	5.89e-06	5.82e-05	CcSEcCtD
Ziprasidone—Nausea—Pregabalin—epilepsy syndrome	5.77e-06	5.7e-05	CcSEcCtD
Ziprasidone—Vomiting—Gabapentin—epilepsy syndrome	5.66e-06	5.59e-05	CcSEcCtD
Ziprasidone—Rash—Gabapentin—epilepsy syndrome	5.61e-06	5.55e-05	CcSEcCtD
Ziprasidone—Dermatitis—Gabapentin—epilepsy syndrome	5.61e-06	5.54e-05	CcSEcCtD
Ziprasidone—Headache—Gabapentin—epilepsy syndrome	5.58e-06	5.51e-05	CcSEcCtD
Ziprasidone—Hypersensitivity—Topiramate—epilepsy syndrome	5.52e-06	5.45e-05	CcSEcCtD
Ziprasidone—Asthenia—Topiramate—epilepsy syndrome	5.37e-06	5.31e-05	CcSEcCtD
Ziprasidone—Nausea—Gabapentin—epilepsy syndrome	5.29e-06	5.23e-05	CcSEcCtD
Ziprasidone—Diarrhoea—Topiramate—epilepsy syndrome	5.12e-06	5.07e-05	CcSEcCtD
Ziprasidone—Dizziness—Topiramate—epilepsy syndrome	4.95e-06	4.9e-05	CcSEcCtD
Ziprasidone—Vomiting—Topiramate—epilepsy syndrome	4.76e-06	4.71e-05	CcSEcCtD
Ziprasidone—Rash—Topiramate—epilepsy syndrome	4.72e-06	4.67e-05	CcSEcCtD
Ziprasidone—Dermatitis—Topiramate—epilepsy syndrome	4.72e-06	4.66e-05	CcSEcCtD
Ziprasidone—Headache—Topiramate—epilepsy syndrome	4.69e-06	4.64e-05	CcSEcCtD
Ziprasidone—Nausea—Topiramate—epilepsy syndrome	4.45e-06	4.4e-05	CcSEcCtD
Ziprasidone—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	4.18e-07	6.86e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	4.17e-07	6.85e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	4.14e-07	6.8e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	4.12e-07	6.77e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—POMC—epilepsy syndrome	4.11e-07	6.75e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	4.11e-07	6.75e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	4.11e-07	6.74e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—SRC—epilepsy syndrome	4.08e-07	6.7e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—SRC—epilepsy syndrome	4.08e-07	6.7e-06	CbGpPWpGaD
Ziprasidone—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.07e-07	6.68e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	4.05e-07	6.65e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	4.05e-07	6.65e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	4.05e-07	6.64e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.04e-07	6.64e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—POMC—epilepsy syndrome	4.04e-07	6.63e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—POMC—epilepsy syndrome	4.04e-07	6.63e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	4.03e-07	6.62e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.03e-07	6.61e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.03e-07	6.61e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	4.03e-07	6.61e-06	CbGpPWpGaD
Ziprasidone—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.02e-07	6.6e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ALB—epilepsy syndrome	4.02e-07	6.59e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.01e-07	6.59e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	4.01e-07	6.58e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	4e-07	6.57e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	3.98e-07	6.54e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	3.98e-07	6.53e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	3.98e-07	6.53e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.97e-07	6.52e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	3.97e-07	6.52e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	3.97e-07	6.51e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.96e-07	6.51e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	3.96e-07	6.5e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.95e-07	6.49e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.95e-07	6.48e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.95e-07	6.48e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	3.94e-07	6.47e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.93e-07	6.45e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—JUN—epilepsy syndrome	3.92e-07	6.43e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	3.91e-07	6.41e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—SRC—epilepsy syndrome	3.9e-07	6.41e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	3.89e-07	6.38e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.89e-07	6.38e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-07	6.37e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.88e-07	6.37e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—JUN—epilepsy syndrome	3.87e-07	6.35e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	3.86e-07	6.34e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	3.85e-07	6.32e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	3.85e-07	6.31e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.83e-07	6.29e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—epilepsy syndrome	3.83e-07	6.28e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	3.83e-07	6.28e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	3.81e-07	6.26e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	3.8e-07	6.24e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	3.77e-07	6.19e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	3.76e-07	6.17e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	3.75e-07	6.16e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	3.75e-07	6.16e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	3.72e-07	6.11e-06	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—AKT1—epilepsy syndrome	3.72e-07	6.1e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	3.7e-07	6.07e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.69e-07	6.06e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	3.69e-07	6.06e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	3.68e-07	6.05e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ALB—epilepsy syndrome	3.68e-07	6.04e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.66e-07	6.01e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	3.65e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	3.65e-07	5.99e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.65e-07	5.98e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.64e-07	5.98e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	3.64e-07	5.97e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.63e-07	5.96e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.63e-07	5.95e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.6e-07	5.91e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	3.59e-07	5.9e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-07	5.9e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.59e-07	5.9e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	3.58e-07	5.88e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.57e-07	5.86e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.56e-07	5.84e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.55e-07	5.83e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.54e-07	5.82e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—SRC—epilepsy syndrome	3.52e-07	5.77e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.51e-07	5.77e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	3.51e-07	5.77e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.51e-07	5.75e-06	CbGpPWpGaD
Ziprasidone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.5e-07	5.75e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	3.49e-07	5.73e-06	CbGpPWpGaD
Ziprasidone—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.48e-07	5.72e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	3.47e-07	5.69e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—SRC—epilepsy syndrome	3.47e-07	5.69e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.46e-07	5.69e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	3.45e-07	5.67e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.43e-07	5.62e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	3.42e-07	5.62e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—TH—epilepsy syndrome	3.41e-07	5.6e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AGT—epilepsy syndrome	3.41e-07	5.6e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	3.4e-07	5.57e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.39e-07	5.56e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	3.38e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—RELA—epilepsy syndrome	3.38e-07	5.54e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	3.37e-07	5.53e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	3.36e-07	5.51e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	3.35e-07	5.5e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—APOE—epilepsy syndrome	3.34e-07	5.48e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.33e-07	5.47e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	3.32e-07	5.45e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.32e-07	5.44e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	3.31e-07	5.44e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.31e-07	5.43e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	3.3e-07	5.42e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.29e-07	5.41e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.29e-07	5.41e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.29e-07	5.41e-06	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	3.29e-07	5.4e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	3.28e-07	5.38e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.26e-07	5.36e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	3.26e-07	5.35e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	3.26e-07	5.35e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	3.26e-07	5.35e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.26e-07	5.35e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	3.25e-07	5.34e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.25e-07	5.34e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.24e-07	5.32e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.23e-07	5.3e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	3.22e-07	5.28e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	3.21e-07	5.27e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.2e-07	5.25e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	3.19e-07	5.24e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	3.18e-07	5.22e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	3.17e-07	5.21e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.16e-07	5.19e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	3.13e-07	5.14e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	3.12e-07	5.13e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	3.08e-07	5.05e-06	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.07e-07	5.05e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.05e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	3.05e-07	5e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	3.03e-07	4.97e-06	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.03e-07	4.97e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	3.02e-07	4.96e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	3.02e-07	4.96e-06	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.02e-07	4.95e-06	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.01e-07	4.94e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	3.01e-07	4.94e-06	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3e-07	4.92e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	3e-07	4.92e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.99e-07	4.91e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	2.98e-07	4.89e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.97e-07	4.88e-06	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.97e-07	4.88e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	2.96e-07	4.87e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.96e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—JUN—epilepsy syndrome	2.96e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.94e-07	4.83e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.94e-07	4.83e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.93e-07	4.82e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.93e-07	4.81e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	2.93e-07	4.8e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	2.91e-07	4.78e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.91e-07	4.77e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	2.9e-07	4.75e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.89e-07	4.74e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.89e-07	4.74e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.88e-07	4.73e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	2.88e-07	4.73e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.87e-07	4.71e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.86e-07	4.69e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.85e-07	4.68e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.85e-07	4.68e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	2.85e-07	4.68e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	2.83e-07	4.65e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.83e-07	4.65e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.83e-07	4.64e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	2.82e-07	4.62e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.81e-07	4.61e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.81e-07	4.61e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.8e-07	4.6e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	2.79e-07	4.58e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.78e-07	4.56e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.77e-07	4.55e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.75e-07	4.52e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.75e-07	4.51e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.74e-07	4.5e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.73e-07	4.49e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	2.73e-07	4.49e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.73e-07	4.48e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.72e-07	4.47e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.7e-07	4.43e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.69e-07	4.42e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—SRC—epilepsy syndrome	2.65e-07	4.36e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	2.65e-07	4.35e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.62e-07	4.3e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	2.61e-07	4.29e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.61e-07	4.28e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.6e-07	4.26e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.59e-07	4.25e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	2.58e-07	4.24e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.58e-07	4.23e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.56e-07	4.21e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.56e-07	4.2e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.54e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.54e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.54e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	2.54e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	2.54e-07	4.16e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.53e-07	4.15e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.52e-07	4.14e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	2.52e-07	4.13e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.5e-07	4.1e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.5e-07	4.1e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.49e-07	4.09e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	2.47e-07	4.05e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.43e-07	3.99e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	2.43e-07	3.98e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-07	3.93e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	2.38e-07	3.9e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.31e-07	3.8e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-07	3.76e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.29e-07	3.76e-06	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	2.24e-07	3.67e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.23e-07	3.66e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.22e-07	3.64e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	2.18e-07	3.59e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.18e-07	3.59e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—epilepsy syndrome	2.17e-07	3.57e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	2.16e-07	3.54e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.95e-07	3.19e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.94e-07	3.18e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.92e-07	3.16e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.88e-07	3.08e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.88e-07	3.08e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-07	3.07e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	1.82e-07	2.98e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.79e-07	2.94e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.77e-07	2.9e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.71e-07	2.81e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	2.71e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	1.62e-07	2.66e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.62e-07	2.66e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.62e-07	2.66e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	2.65e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.61e-07	2.64e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-07	2.62e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-07	2.61e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.5e-07	2.46e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.48e-07	2.42e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.15e-07	1.89e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	9.75e-08	1.6e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.52e-08	1.23e-06	CbGpPWpGaD
